Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NBMX - National Boston Medical (was FGRX) -- Ignore unavailable to you. Want to Upgrade?

To: sean who wrote (1100)	3/4/1999 11:41:00 AM
From: William Hayden	Read Replies (2) \| Respond to of 1286

NBMX News!!! (COMTEX) B: NBM REPORTS $630,000 INITIAL SALE OF SAFESHIELD(TM) THROU B: NBM REPORTS $630,000 INITIAL SALE OF SAFESHIELD(TM) THROUGH New Master Distributor, DermaGuard, Inc. TAUNTON, Mass., March 4 /PRNewswire/ -- National Boston Medical (OTC Bulletin Board: NBMX) (NBM) has signed Dermaguard, Inc. of New Orleans, Louisiana, as a Master Distributor for its proprietary SafeShield(TM) anti-microbial barrier lotion. Dermaguard has developed a number of brokers and distributors for SafeShield(TM) in the food service, medical and retail markets, and has placed an initial order for $630,000. "SafeShield has many applications beyond the important use in medical practice," said Dermaguard CEO Alvarez Ferrouillet. "We are excited to work with National Boston Medical to introduce this unique product to a number of markets. These include retail and food service, where there is an increasing awareness of hand-transmitted viruses and bacteria, and clear demand for a durable and highly-effective product like SafeShield." Dermaguard plans to secure more than 70 product brokers for SafeShield and $6 million in sales before the end of the year. As part of its distribution agreement, NBM acquired a 5% ownership in Dermaguard in exchange for 150,000 shares of NBM's common stock. SafeShield is a topical polymeric barrier that can eliminate the need for latex gloves or frequent hand washings. This revolutionary product helps prevent the spread of infectious disease and exposure to hazardous agents through a unique and proprietary, anti-microbial barrier lotion that maintains integrity for three or more hours, even after repeated hand washing. SafeShield is designed for businesses or consumers that are concerned with cross contamination of infectious diseases; damaged skin from latex gloves or frequent hand washing; foodborne illness due to contaminated food handlers; as well as those simply desiring healthy and beautiful hands. National Boston Medical is a developer and marketer of quality healthcare products. It is the exclusive provider of Bontempi medical instruments in North America and on the Internet. NBM is the developer of SafeShield(TM), a topical polymeric barrier that can replace the need for latex gloves or frequent hand washings. NBM also markets Vertason and VertaVac, environmentally-friendly enzymatic cleaning solutions for use in the dental industry. It recently acquired Flex Marketing, Inc., which offers consumer products to the healthcare, fitness, and recreation markets, including the popular Backstroke(R) back massager. NBM's Medical Advisory Board is comprised of twenty-five award-winning medical professionals. For further information, please visit the company's web site at: nbmedical.com. Company contacts: Daniel J. Hoyng, president of NBM, 800-807-2259; Alvarez Ferrouillet, CEO of DermaGuard 504-269-0068; Len Harris or James Dryer, investor relations, 561-655-7575, fax 561-655-2171, e-mail: jamesdryer@aol.com. This press release may contain forward-looking statements, which may be affected by a variety of factors, many of which are beyond the control of the company. These factors include the levels of orders that are received and can be shipped in a quarter; customer order patterns and seasonability; contract mix and shifting production and delivery schedules; manufacturing capacity and yield; cost of labor, raw materials, supplies and equipment; technological changes; competition and competitive pressures on pricing; economic conditions, as well as other risks and uncertainties that are detailed from time to time in the company's filings with the Securities and Exchange Commission. SOURCE National Boston Medical -0- 03/04/99 /CONTACT: Daniel J. Hoyng, president of National Boston Medical, 800-807-2259; or Alvarez Ferrouillet, CEO of Dermaguard, 504-269-0068; or James Dryer or Geoffrey Plank, public & investor relations, 561-655-7575/ /Web site: nbmedical.com (NBMX) CO: National Boston Medical; Dermaguard, Inc. ST: Massachusetts, Louisiana IN: HEA SU: PDT * end of story *